Registration Opening Soon!
ASGCT and FDA will host a virtual scientific workshop over two half days on January 22 and 23, 2025. This free, public event will explore key immunology-related topics that have implications across the class of AAV gene therapies, including immune responses, antibody testing, and redosing strategies.
The workshop will provide valuable insights for professionals in both academia and industry as it addresses pressing challenges in AAV gene therapies and new approaches.
Additionally, attendees will gain important regulatory perspectives from the FDA, offering guidance on how these ongoing issues are being addressed within the regulatory landscape.